UPDATE: MKM Partners Downgrades Amarin Corporation (AMRN) to Neutral
- Futures tread water ahead of Fed meet
- BOJ hikes interest rates for first time in 17 years, to remain accommodative
- Buy the dip in US stocks in case of a 'rate shock' - Goldman
- Shares dip, yen slides as BOJ's landmark policy shift draws eyes
- Nvidia unveils Blackwell, AI chip 'to power this new industrial revolution'
- After-hours movers: ANSYS, National CineMedia, and more
- Midday movers: Google, Pepsi rise; Boeing, Zillow fall
- Midday movers: Adobe, Zillow fall; Micron rises
- After-hours movers: Adobe Systems slumps; Rivian, Ulta Beauty gain
- Midday movers: Tesla, Nvidia fall premarket; Robinhood, Dollar General rise
Amarin (AMRN) Says FDA Decision on ANCHOR SPA Delayed
January 15, 2014 4:06 PM ESTAmarin Corp Plc (NASDAQ: AMRN) announced today that the Division of Metabolism and Endocrinology Products (DMEP) within the U.S. Food and Drug Administration (FDA) notified the company today that a determination on Amarin's request for reconsideration of DMEP's October 2013 decision to rescind the ANCHOR... More
Amarin (AMRN) Ramps Ahead of Expected FDA Decision on ANCHOR SPA
January 15, 2014 1:19 PM ESTShares of Amarin Corp Plc (NASDAQ: AMRN) are strong Wednesday ahead of expected news from the FDA on the company's ANCHOR SPA appeal.
The FDA said in December it plans to complete its review of Amarin's request to re-instate the ANCHOR... More